Ozempic and Mounjaro are popular for quick weight loss. These drugs mimic gut hormones to reduce hunger. However, stopping ...

Designs for Health®, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today ...

Say local manufacturing improves convenience of long-term therapy, stabilises supply chains and lowers prices.

Pakistan’s healthcare landscape has entered a pivotal phase in the management of diabetes and obesity. For years, advanced ...

Diabetes is a chronic, (mostly) irreversible condition, in which the body has high blood sugar because it doesn't produce enough insulin, or can't use it effectively. Those who suffer from Diabetes, ...

Under the agreement, Eli Lilly will continue to market tirzepatide under brand name Mounjaro, while Cipla will have the ...

Favorites from The Inkey List, Zo Skin Health, and more provide radiance and firmness in a bottle Of all the groundbreaking ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...